271 related articles for article (PubMed ID: 15735005)
1. A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk.
Narla G; Difeo A; Reeves HL; Schaid DJ; Hirshfeld J; Hod E; Katz A; Isaacs WB; Hebbring S; Komiya A; McDonnell SK; Wiley KE; Jacobsen SJ; Isaacs SD; Walsh PC; Zheng SL; Chang BL; Friedrichsen DM; Stanford JL; Ostrander EA; Chinnaiyan AM; Rubin MA; Xu J; Thibodeau SN; Friedman SL; Martignetti JA
Cancer Res; 2005 Feb; 65(4):1213-22. PubMed ID: 15735005
[TBL] [Abstract][Full Text] [Related]
2. Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread.
Narla G; DiFeo A; Yao S; Banno A; Hod E; Reeves HL; Qiao RF; Camacho-Vanegas O; Levine A; Kirschenbaum A; Chan AM; Friedman SL; Martignetti JA
Cancer Res; 2005 Jul; 65(13):5761-8. PubMed ID: 15994951
[TBL] [Abstract][Full Text] [Related]
3. The role of KLF6 and its splice variants in cancer therapy.
DiFeo A; Martignetti JA; Narla G
Drug Resist Updat; 2009; 12(1-2):1-7. PubMed ID: 19097929
[TBL] [Abstract][Full Text] [Related]
4. KLF6, a candidate tumor suppressor gene mutated in prostate cancer.
Narla G; Heath KE; Reeves HL; Li D; Giono LE; Kimmelman AC; Glucksman MJ; Narla J; Eng FJ; Chan AM; Ferrari AC; Martignetti JA; Friedman SL
Science; 2001 Dec; 294(5551):2563-6. PubMed ID: 11752579
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte growth factor enhances alternative splicing of the Kruppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1.
Muñoz Ú; Puche JE; Hannivoort R; Lang UE; Cohen-Naftaly M; Friedman SL
Mol Cancer Res; 2012 Sep; 10(9):1216-27. PubMed ID: 22859706
[TBL] [Abstract][Full Text] [Related]
6. In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma.
Narla G; Kremer-Tal S; Matsumoto N; Zhao X; Yao S; Kelley K; Tarocchi M; Friedman SL
Oncogene; 2007 Jun; 26(30):4428-34. PubMed ID: 17297474
[TBL] [Abstract][Full Text] [Related]
7. Growth inhibitory effect of Krüppel-like factor 6 on human prostatic carcinoma and renal carcinoma cell lines.
Cheng XF; Li D; Zhuang M; Chen ZY; Lu DX; Hattori T
Tohoku J Exp Med; 2008 Sep; 216(1):35-45. PubMed ID: 18719336
[TBL] [Abstract][Full Text] [Related]
8. Functional role of the KLF6 tumour suppressor gene in gastric cancer.
Sangodkar J; Shi J; DiFeo A; Schwartz R; Bromberg R; Choudhri A; McClinch K; Hatami R; Scheer E; Kremer-Tal S; Martignetti JA; Hui A; Leung WK; Friedman SL; Narla G
Eur J Cancer; 2009 Mar; 45(4):666-76. PubMed ID: 19101139
[TBL] [Abstract][Full Text] [Related]
9. Functional inactivation of the KLF6 tumor suppressor gene by loss of heterozygosity and increased alternative splicing in glioblastoma.
Camacho-Vanegas O; Narla G; Teixeira MS; DiFeo A; Misra A; Singh G; Chan AM; Friedman SL; Feuerstein BG; Martignetti JA
Int J Cancer; 2007 Sep; 121(6):1390-5. PubMed ID: 17514651
[TBL] [Abstract][Full Text] [Related]
10. Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.
Ito G; Uchiyama M; Kondo M; Mori S; Usami N; Maeda O; Kawabe T; Hasegawa Y; Shimokata K; Sekido Y
Cancer Res; 2004 Jun; 64(11):3838-43. PubMed ID: 15172991
[TBL] [Abstract][Full Text] [Related]
11. Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma.
Yea S; Narla G; Zhao X; Garg R; Tal-Kremer S; Hod E; Villanueva A; Loke J; Tarocchi M; Akita K; Shirasawa S; Sasazuki T; Martignetti JA; Llovet JM; Friedman SL
Gastroenterology; 2008 May; 134(5):1521-31. PubMed ID: 18471523
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of the tumor suppressor Krüppel-like factor 6 (KLF6) by mutation or decreased expression in hepatocellular carcinomas.
Pan XC; Chen Z; Chen F; Chen XH; Jin HY; Xu XY
J Zhejiang Univ Sci B; 2006 Oct; 7(10):830-6. PubMed ID: 16972326
[TBL] [Abstract][Full Text] [Related]
13. Kruppel-like factor 6 germ-line mutations are infrequent in Finnish hereditary prostate cancer.
Koivisto PA; Hyytinen ER; Matikainen M; Tammela TL; Ikonen T; Schleutker J
J Urol; 2004 Aug; 172(2):506-7. PubMed ID: 15247715
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the prostate cancer susceptibility gene KLF6 in human and mouse prostate cancers.
Chiam K; Ryan NK; Ricciardelli C; Day TK; Buchanan G; Ochnik AM; Murti K; Selth LA; ; Butler LM; Tilley WD; Bianco-Miotto T
Prostate; 2013 Jan; 73(2):182-93. PubMed ID: 22782870
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Kruppel-like factor 6 tumor suppressor activity by acetylation.
Li D; Yea S; Dolios G; Martignetti JA; Narla G; Wang R; Walsh MJ; Friedman SL
Cancer Res; 2005 Oct; 65(20):9216-25. PubMed ID: 16230382
[TBL] [Abstract][Full Text] [Related]
16. Biology of Krüppel-like factor 6 transcriptional regulator in cell life and death.
Andreoli V; Gehrau RC; Bocco JL
IUBMB Life; 2010 Dec; 62(12):896-905. PubMed ID: 21154818
[TBL] [Abstract][Full Text] [Related]
17. Deletion, mutation, and loss of expression of KLF6 in human prostate cancer.
Chen C; Hyytinen ER; Sun X; Helin HJ; Koivisto PA; Frierson HF; Vessella RL; Dong JT
Am J Pathol; 2003 Apr; 162(4):1349-54. PubMed ID: 12651626
[TBL] [Abstract][Full Text] [Related]
18. Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1.
Benzeno S; Narla G; Allina J; Cheng GZ; Reeves HL; Banck MS; Odin JA; Diehl JA; Germain D; Friedman SL
Cancer Res; 2004 Jun; 64(11):3885-91. PubMed ID: 15172998
[TBL] [Abstract][Full Text] [Related]
19. The SV2 variant of KLF6 is down-regulated in hepatocellular carcinoma and displays anti-proliferative and pro-apoptotic functions.
Hanoun N; Bureau C; Diab T; Gayet O; Dusetti N; Selves J; Vinel JP; Buscail L; Cordelier P; Torrisani J
J Hepatol; 2010 Nov; 53(5):880-8. PubMed ID: 20801538
[TBL] [Abstract][Full Text] [Related]
20. Mutation screening and association study of the candidate prostate cancer susceptibility genes MSR1, PTEN, and KLF6.
Bar-Shira A; Matarasso N; Rosner S; Bercovich D; Matzkin H; Orr-Urtreger A
Prostate; 2006 Jul; 66(10):1052-60. PubMed ID: 16598737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
